GlassScriptPhysician profile
Debra J Wattenberg
NPI 1437191236
$2,758.93
in general payments reported to CMS, 2019-2025
21 companies · $512 in 2025
The $512 reported for 2025 was less than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $803 · 2020: $221 · 2021: $439 · 2022: $436 · 2023: $135 · 2024: $212 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $859.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $626.02 | 2019-2022 | |
| Galderma Laboratories, L.P. | $407.13 | 2019-2025 | |
| Abbvie INC. | $248.97 | 2023-2025 | |
| Leo Pharma INC. | $204.17 | 2019-2025 | Anzupgo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $200.57 | 2019-2022 | |
| Pfizer INC. | $198.08 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $139.94 | 2022-2025 | Winlevi, Absorica Ld |
| Revance Therapeutics, INC. | $139.63 | 2024-2025 | Daxxify |
| Encore Dermatology INC. | $80.67 | 2019-2020 | |
| Merz North America, INC. | $76.85 | 2019-2020 | |
| Incyte Corporation | $68.71 | 2022-2025 | Opzelura |
| Aclaris Therapeutics, INC. | $60.20 | 2019 | |
| Almirall LLC | $58.60 | 2019-2024 | Klisyri |
| Journey Medical Corporation | $48.34 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $46.67 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $41.10 | 2019-2020 | |
| Amgen INC. | $26.97 | 2025 | Otezla |
| Epi Health, LLC | $24.06 | 2019 | |
| Verrica Pharmaceuticals INC. | $22.49 | 2025 | Ycanth |
| Solta Medical, A Division of Bausch Health US, LLC | $21.81 | 2022 | |
| Vyne Pharmaceuticals INC. | $17.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Wattenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.